Meag Munich Ergo’s Exelon EXC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,219,088
| Closed | -$42.2M | – | 200 |
|
|
2024
Q2 | $42.2M | Hold |
1,219,088
| – | – | 1.4% | 33 |
|
|
2024
Q1 | $45.8M | Hold |
1,219,088
| – | – | 1.66% | 25 |
|
|
2023
Q4 | $43.8M | Buy |
1,219,088
+175,602
| +17% | +$6.76M | 1.66% | 21 |
|
|
2023
Q3 | $39.4M | Buy |
1,043,486
+13,969
| +1% | +$569K | 1.72% | 22 |
|
|
2023
Q2 | $41.9M | Sell |
1,029,517
-12,933
| -1% | -$535K | 1.83% | 17 |
|
|
2023
Q1 | $43.7M | Sell |
1,042,450
-9,577
| -0.9% | -$399K | 2.06% | 16 |
|
|
2022
Q4 | $45.5M | Buy |
1,052,027
+183,958
| +21% | +$7.27M | 2.45% | 11 |
|
|
2022
Q3 | $32.5M | Sell |
868,069
-110,300
| -11% | -$4.88M | 1.97% | 23 |
|
|
2022
Q2 | $44.3M | Buy |
978,369
+222,612
| +29% | +$10.5M | 2.65% | 8 |
|
|
2022
Q1 | $36.4M | Sell |
755,757
-38,421
| -5% | -$1.63M | 2.63% | 10 |
|
|
2021
Q4 | $32.6M | Buy |
+794,178
| New | +$29.9M | 2.32% | 13 |
|
|
2020
Q1 | – | Sell |
-20,744
| Closed | -$671K | – | 306 |
|
|
2019
Q4 | $671K | Sell |
20,744
-70,913
| -77% | -$2.3M | 0.07% | 244 |
|
|
2019
Q3 | $3.16M | Buy |
91,657
+40,300
| +78% | +$1.35M | 0.16% | 143 |
|
|
2019
Q2 | $1.75M | Hold |
51,357
| – | – | 0.14% | 167 |
|
|
2019
Q1 | $1.82M | Buy |
+51,357
| New | +$1.75M | 0.15% | 161 |
|
|
2018
Q4 | – | Sell |
-298,598
| Closed | -$9.07M | – | 358 |
|
|
2018
Q3 | $9.07M | Sell |
298,598
-16,145
| -5% | -$497K | 0.54% | 52 |
|
|
2018
Q2 | $9.57M | Sell |
314,743
-251,493
| -44% | -$7.2M | 0.59% | 41 |
|
|
2018
Q1 | $15.5M | Buy |
566,236
+271,210
| +92% | +$7.32M | 0.63% | 32 |
|
|
2017
Q4 | $8.32M | Sell |
295,026
-500,967
| -63% | -$14.4M | 0.32% | 91 |
|
|
2017
Q3 | $21.3M | Sell |
795,993
-239,005
| -23% | -$6.39M | 0.87% | 28 |
|
|
2017
Q2 | $26.4M | Sell |
1,034,998
-225,679
| -18% | -$5.74M | 1.17% | 13 |
|
|
2017
Q1 | $32M | Buy |
1,260,677
+350,213
| +38% | +$8.92M | 1.26% | 8 |
|
|
2016
Q4 | $23.3M | Buy |
910,464
+209,770
| +30% | +$4.97M | 1.09% | 17 |
|
|
2016
Q3 | $16.6M | Buy |
+700,694
| New | +$17.6M | 0.82% | 31 |
|
|
2016
Q2 | – | Sell |
-783,223
| Closed | -$19.9M | – | 192 |
|
|
2016
Q1 | $19.9M | Hold |
783,223
| – | – | 1.03% | 24 |
|
|
2015
Q4 | $15.5M | Buy |
783,223
+125,434
| +19% | +$2.54M | 0.78% | 36 |
|
|
2015
Q3 | $13.8M | Sell |
657,789
-246,657
| -27% | -$5.54M | 0.74% | 41 |
|
|
2015
Q2 | $20.2M | Buy |
904,446
+200,498
| +28% | +$4.8M | 1.04% | 21 |
|
|
2015
Q1 | $16.8M | Hold |
703,948
| – | – | 0.8% | 36 |
|
|
2014
Q4 | $19.1M | Buy |
703,948
+197,733
| +39% | +$5.07M | 0.87% | 31 |
|
|
2014
Q3 | $12.3M | Buy |
506,215
+292,243
| +137% | +$6.84M | 0.57% | 54 |
|
|
2014
Q2 | $5.6M | Buy |
+213,972
| New | +$5.46M | 0.24% | 111 |
|
|
2014
Q1 | – | Sell |
-952,569
| Closed | -$18.6M | – | 218 |
|
|
2013
Q4 | $18.6M | Buy |
952,569
+227,393
| +31% | +$4.58M | 1.09% | 19 |
|
|
2013
Q3 | $15.3M | Buy |
725,176
+650,534
| +872% | +$14.2M | 1.07% | 29 |
|
|
2013
Q2 | $1.65M | Buy |
+74,642
| New | +$1.81M | 0.12% | 145 |
|
Other funds holding EXC
Meag Munich Ergo's EXC Position: Q3 2024 in Review
Meag Munich Ergo sold out of Exelon (EXC) in Q3 2024, closing a stake of 1,219,088 shares — an estimated $42.2M sold.
Meag Munich Ergo first reported a position in EXC in Q2 2013 and held it in 35 quarters. The position peaked at $45.8M in Q1 2024. 1,051 funds tracked by Wall St. Rank hold EXC as of Q3 2024.
- Meag Munich Ergo reported no remaining Exelon position as of Q3 2024 after selling out during the quarter.
- Meag Munich Ergo sold 1,219,088 Exelon shares in Q3 2024, an estimated $42.2M.
- Meag Munich Ergo first reported a position in Exelon in Q2 2013 and held it in 35 quarters.
- Meag Munich Ergo's Exelon position peaked at $45.8M in Q1 2024.
- 1,051 funds tracked by Wall St. Rank held Exelon as of Q3 2024.
Based on Meag Munich Ergo's 13F filing for Q3 2024, filed 11 Oct 2024.